ASCO's profile picture. Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.

ASCO

@ASCO

Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.

고정된 트윗

Getting a head start on your 2026 calendar? Don't miss out on our meetings—the ultimate Place to Be to connect with peers, discover groundbreaking cancer research, and gain clinical insights. Where will we see you this year? Let us know in the comments.


Explore the GI26 program to find out which advances in GI cancers will be featured at this year’s symposium: asco.org/gi-program If you’re joining us, whether online or in person, early registration closes tomorrow, Dec. 3, so register today: brnw.ch/21wY1wG

ASCO's tweet image. Explore the GI26 program to find out which advances in GI cancers will be featured at this year’s symposium: asco.org/gi-program 

If you’re joining us, whether online or in person, early registration closes tomorrow, Dec. 3, so register today: brnw.ch/21wY1wG

#ASCOAdvocacy applauds the House for passing the bipartisan Give Kids a Chance Act, which calls for accelerating research and drug development for rare pediatric diseases, including cancer.

The House just unanimously passed the Give Kids a Chance Act to accelerate drug research and development for rare pediatric diseases, including cancer. This commonsense bill will give families of children facing rare diseases much-needed hope.

RepGuthrie's tweet image. The House just unanimously passed the Give Kids a Chance Act to accelerate drug research and development for rare pediatric diseases, including cancer.

This commonsense bill will give families of children facing rare diseases much-needed hope.


The 5-year survival rate for chronic myeloid leukemia (CML) has risen from 22% in 1970s to over 70% today, thanks to NCI-led research. Tell your lawmakers to support cancer research funding: brnw.ch/21wY0Cu #SaveResearchStopCancer #ASCOAdvocacy

ASCO's tweet image. The 5-year survival rate for chronic myeloid leukemia (CML) has risen from 22% in 1970s to over 70% today, thanks to NCI-led research. 

Tell your lawmakers to support cancer research funding: brnw.ch/21wY0Cu
#SaveResearchStopCancer #ASCOAdvocacy

ASCO 님이 재게시함

Should be a good time! Some great discussions!

Only 3 weeks left to join the IASLC | @ASCO 2025 NACLC! Don’t miss expert debates, case discussions + networking. Hotel block closes today⏲️. Save 20% w/ code CHICAGO20. Virtual on-demand available. Claim your spot! bit.ly/4oL1rl4

IASLC's tweet image. Only 3 weeks left to join the IASLC | @ASCO 2025 NACLC! 

Don’t miss expert debates, case discussions + networking. 

Hotel block closes today⏲️. 
Save 20% w/ code CHICAGO20. 
Virtual on-demand available. 

Claim your spot! bit.ly/4oL1rl4


ASCO 님이 재게시함

Grateful to ASCO @ASCO for the wonderful ASCO LDP Education Scholars program 2024-2025. Learnt in depth on Education and Learning principles. Lot of scope to improve Oncology Education. Excellent classmates and Mentors !

sujithonco's tweet image. Grateful to ASCO @ASCO for the wonderful ASCO LDP Education Scholars program 2024-2025.

Learnt in depth on Education and Learning principles. 
Lot of scope to improve Oncology  Education. 
Excellent classmates and Mentors  !
sujithonco's tweet image. Grateful to ASCO @ASCO for the wonderful ASCO LDP Education Scholars program 2024-2025.

Learnt in depth on Education and Learning principles. 
Lot of scope to improve Oncology  Education. 
Excellent classmates and Mentors  !

The draft guideline update protocol, stages I-IIIa #nsclc update, is now available for open comment. Provide your feedback to us by December 15. Learn more: brnw.ch/21wXYAr #LungCancer

ASCO's tweet image. The draft guideline update protocol, stages I-IIIa #nsclc update, is now available for open comment. Provide your feedback to us by December 15. 

Learn more: brnw.ch/21wXYAr     
#LungCancer

Like Dr. Vadehra, find your people at #GI26. Early registration closes Dec. 3; register today: brnw.ch/21wXYvk

Finding your people in medicine can be hard. But once you’ve got good people in your corner, the journey gets better. Seeing @TimothyJBrownMD is always a highlight of any meeting. I may be biased but I think my group of people is dope and I’m glad to have seen y’all at #GI25.



Read our initial assessment of the 2026 Medicare Hospital Outpatient Payment & Ambulatory Surgical Center final rule. It finalizes updates to hospital payment rates, site-neutral payments, and the inpatient only list: brnw.ch/21wXQZl #ASCOAdvocacy

ASCO's tweet image. Read our initial assessment of the 2026 Medicare Hospital Outpatient Payment & Ambulatory Surgical Center final rule. 

It finalizes updates to hospital payment rates, site-neutral payments, and the inpatient only list: brnw.ch/21wXQZl
#ASCOAdvocacy

This November, we were proud to co-host an International Clinical Research Course in Istanbul, Turkey alongside the Turkish Society of Medical Oncology. Thank you to our partners at TSMO for organizing such an important and informative event! #ASCOGlobalImpact

ASCO's tweet image. This November, we were proud to co-host an International Clinical Research Course in Istanbul, Turkey alongside the Turkish Society of Medical Oncology. Thank you to our partners at TSMO for organizing such an important and informative event! #ASCOGlobalImpact
ASCO's tweet image. This November, we were proud to co-host an International Clinical Research Course in Istanbul, Turkey alongside the Turkish Society of Medical Oncology. Thank you to our partners at TSMO for organizing such an important and informative event! #ASCOGlobalImpact
ASCO's tweet image. This November, we were proud to co-host an International Clinical Research Course in Istanbul, Turkey alongside the Turkish Society of Medical Oncology. Thank you to our partners at TSMO for organizing such an important and informative event! #ASCOGlobalImpact

Our CMO @jrgralow joined @NPR to discuss the impact unstable federal funding for cancer research has on the U.S.’s ability to attract & retain talented researchers & physicians. Funding & other challenges threaten to accelerate “brain drain.” brnw.ch/21wXP1F #ASCOAdvocacy

ASCO's tweet image. Our CMO @jrgralow joined @NPR to discuss the impact unstable federal funding for cancer research has on the U.S.’s ability to attract & retain talented researchers & physicians. Funding & other challenges threaten to accelerate “brain drain.” brnw.ch/21wXP1F #ASCOAdvocacy

We are excited to collaborate with our International Cancer Corps colleagues at the Instituto Oncologico del Oriente Boliviano in Santa Cruz, Bolivia! We successfully hosted an MCMC focused on breast cancer management. Thank you to all involved! #ASCOGlobalImpact

ASCO's tweet image. We are excited to collaborate with our International Cancer Corps colleagues at the Instituto Oncologico del Oriente Boliviano in Santa Cruz, Bolivia! We successfully hosted an MCMC focused on breast cancer management. Thank you to all involved! #ASCOGlobalImpact

The treatment landscape for advanced UC has changed considerably in recent years. For #ASCODailyNews, @tompowles1 and Dr. Catherine Graham discuss EV + pembro's place as standard 1L therapy & the potential for disease progression on avelumab: brnw.ch/21wXMdx

ASCO's tweet image. The treatment landscape for advanced UC has changed considerably in recent years. For #ASCODailyNews, @tompowles1 and Dr. Catherine Graham discuss EV + pembro's place as standard 1L therapy & the potential for disease progression on avelumab: brnw.ch/21wXMdx

Tell us who inspires you! The @ConquerCancerFd Women Who Conquer Cancer Mentorship Award deadline is approaching. Recognize a woman leader who has made an outstanding commitment to mentoring. Nominate today! Due Dec 12th: brnw.ch/21wXIze

ASCO's tweet image. Tell us who inspires you! The @ConquerCancerFd Women Who Conquer Cancer Mentorship Award deadline is approaching. Recognize a woman leader who has made an outstanding commitment to mentoring. Nominate today! 

Due Dec 12th: brnw.ch/21wXIze

We were in Mumbai, India this month for the International Palliative Care Course (IPCC), held in partnership with @TataMemorial. Participants and esteemed faculty collaborated on advancing strategies to develop and sustain PC services. Thank you, Tata Memorial! #ASCOGlobalImpact

ASCO's tweet image. We were in Mumbai, India this month for the International Palliative Care Course (IPCC), held in partnership with @TataMemorial. Participants and esteemed faculty collaborated on advancing strategies to develop and sustain PC services. Thank you, Tata Memorial! #ASCOGlobalImpact
ASCO's tweet image. We were in Mumbai, India this month for the International Palliative Care Course (IPCC), held in partnership with @TataMemorial. Participants and esteemed faculty collaborated on advancing strategies to develop and sustain PC services. Thank you, Tata Memorial! #ASCOGlobalImpact
ASCO's tweet image. We were in Mumbai, India this month for the International Palliative Care Course (IPCC), held in partnership with @TataMemorial. Participants and esteemed faculty collaborated on advancing strategies to develop and sustain PC services. Thank you, Tata Memorial! #ASCOGlobalImpact

Read it now! ASCO Expert & @ClevelandClinic medical oncologist Dr. Joel Saltzman shares his insights on new #CancerResearch suggesting #GLP1s may boost survival in #ColonCancer in @EverydayHealth article. Read his full expert perspective: brnw.ch/21wXI42

ASCO's tweet image. Read it now! ASCO Expert & @ClevelandClinic medical oncologist Dr. Joel Saltzman shares his insights on new #CancerResearch suggesting #GLP1s may boost survival in #ColonCancer in @EverydayHealth article.

Read his full expert perspective: brnw.ch/21wXI42

Voting in the ASCO Election is open now until December 8! Meet the candidates for the Nominating Committee – Undesignated Member seat. Learn more about each candidate and make your voice heard: brnw.ch/21wXI27

ASCO's tweet image. Voting in the ASCO Election is open now until December 8! Meet the candidates for the Nominating Committee – Undesignated Member seat. Learn more about each candidate and make your voice heard: brnw.ch/21wXI27

ASCO 님이 재게시함

Only 3 weeks left to join the IASLC | @ASCO 2025 NACLC! Don’t miss expert debates, case discussions + networking. Hotel block closes today⏲️. Save 20% w/ code CHICAGO20. Virtual on-demand available. Claim your spot! bit.ly/4oL1rl4

IASLC's tweet image. Only 3 weeks left to join the IASLC | @ASCO 2025 NACLC! 

Don’t miss expert debates, case discussions + networking. 

Hotel block closes today⏲️. 
Save 20% w/ code CHICAGO20. 
Virtual on-demand available. 

Claim your spot! bit.ly/4oL1rl4

There’s still time to apply for the @ConquerCancerFd YIA Special Competitions. This mentored award supports your transition from fellowship to faculty. Don’t miss this opportunity! Deadlines vary. Learn more and apply today: brnw.ch/21wXG71 #ResearchFunding #OncTwitter


Join a multidisciplinary community dedicated to comprehensive and coordinated patient-centered care for GI cancers for three days of innovative science and networking. Early registration ends December 3. Register: brnw.ch/21wXFGQ #GI26


Voting in the ASCO Election is open now until December 8! Meet the candidates for the Board of Directors – Undesignated Member seat. Learn more about each candidate and make your voice heard: brnw.ch/21wXDF4

ASCO's tweet image. Voting in the ASCO Election is open now until December 8! Meet the candidates for the Board of Directors – Undesignated Member seat. 

Learn more about each candidate and make your voice heard: brnw.ch/21wXDF4

Loading...

Something went wrong.


Something went wrong.